_:n0563d5d74c2b452ab3e514effa625224xb2
<http://schema.org/text>
"[i]&nbsp;Georgiev V., Chavdarov D., Petkov V., Kirilov B. &ldquo;Effect of centrophenoxine on acetylcholine release in perfused cerebral ventricles of cats under dynamic electrophysiological control.&rdquo;&nbsp;Acta Physiologica et Pharmacologica Bulgaria. 1979;5(3):59-66. (source)\r\n[ii]&nbsp;Marcer D., Hopkins S.M. &ldquo;The differential effects of meclofenoxate on memory loss in the elderly.&rdquo;&nbsp;Age and Ageing. 1977 May;6(2):123-31. (source)\r\n[iii]&nbsp;Sharma D., Singh R. &ldquo;Centrophenoxine activates acetylcholinesterase activity in hippocampus of aged rats.&rdquo;&nbsp;Indian Journal of Experimental Biology. 1995 May;33(5):365-8. (source)\r\n[iv]&nbsp;Wood P.L., P&eacute;loquin A. &ldquo;Increases in choline levels in rat brain elicited by meclofenoxate.&rdquo;&nbsp;Neuropharmacology&nbsp;1982 Apr;21(4):349-54. (source)\r\n[v]&nbsp;Katz M.L., Robison W.G. Jr. &ldquo;What is lipofuscin? Defining characteristics and differentiation from other autofluorescent lysosomal storage bodies.&rdquo;&nbsp;Archives of Gerontology and Geriatrics. 2002 May-Jun;34(3):169-84. (source)\r\n[vi]&nbsp;Nandy K., Bourne G.H. &ldquo;Effect of centrophenoxine on the lipofuscin pigments in the neurones of senile guinea-pigs.&rdquo;&nbsp;Nature. 1966 Apr 16;210(5033):313-4. (source)\r\n[vii]&nbsp;Lewis J.A., Young R. &ldquo;Deanol and methylphenidate in minimal brain dysfunction.&rdquo;&nbsp;Clinical Pharmacology and Therapeutics. 1975 May;17(5):534-40. (source)\r\n[viii]&nbsp;Roy D., Pathak D.N., Singh R. &ldquo;Effect of centrophenoxine on the antioxidative enzymes in various regions of the aging rat brain.&rdquo;Experimental Gerontology. 1983;18(3):185-97. (source)\r\n[ix]&nbsp;Ludwig-Festl M., Gr&auml;ter B., Bayreuther K. &ldquo;[Increase in cell metabolism in normal, diploid human glial cells in stationary cell cultures induced by meclofenoxate].&rdquo;&nbsp;Arzneimittel-forschung. 1983;33(4):495-501. (source)\r\n[x]&nbsp;F&uuml;l&ouml;p T. Jr., W&oacute;rum .I, Csongor J., Le&ouml;vey A., Szab&oacute; T., P&eacute;k G., Zs -Nagy I. &ldquo;Effects of centrophenoxine on body composition and some biochemical parameters of demented elderly people as revealed in a double-blind clinical trial.&rdquo;&nbsp;Archives of Gerontology and Geriatrics. 1990 May-Jun;10(3):239-51. (source)\r\n[xi]&nbsp;Sharma D., Maurya A.K., Singh R. &ldquo;Age-related decline in multiple unit action potentials of CA3 region of rat hippocampus: correlation with lipid peroxidation and lipofuscin concentration and the effect of centrophenoxine.&rdquo;&nbsp;Neurobiology of Aging. 1993 Jul-Aug;14(4):319-30. (source)\r\n[xii]&nbsp;P&eacute;k G., F&uuml;l&ouml;p T., Zs-Nagy I. &ldquo;Gerontopsychological studies using NAI (&lsquo;N&uuml;rnberger Alters-Inventar&rsquo;) on patients with organic psychosyndrome (DSM III, Category 1) treated with centrophenoxine in a double blind, comparative, randomized clinical trial.&rdquo;&nbsp;Archives of Gerontology and Geriatrics. 1989 Jul;9(1):17-30. (source)\r\n[xiii]&nbsp;Nandy K. &ldquo;Centrophenoxine: effects on aging mammalian brain.&rdquo;Journal of the American Geriatrics Society. 1978 Feb;26(2):74-81. (source)\r\n[xiv]&nbsp;Casey D.E. &ldquo;Mood alterations during deanol therapy.&rdquo;Psychopharmacology (Berlin). 1979 Apr 11;62(2):187-91. (source)"
<https://nootropicsexpert.com/centrophenoxine/comment-page-2/?replytocom=51895>